Synopsis
0
EU WC
0
KDMF
0
VMF
0
Canada
0
Australia
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
Upgrade, download data, analyse, strategize, subscribe with us 
INTERMEDIATES SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Global Sales Information
Market Place
FDF DOSSIERS
Reply
13 Feb 2018
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A LEVOCABASTINE HYDROCHLORIDE manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of LEVOCABASTINE HYDROCHLORIDE, including repackagers and relabelers. The FDA regulates LEVOCABASTINE HYDROCHLORIDE manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. LEVOCABASTINE HYDROCHLORIDE API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of LEVOCABASTINE HYDROCHLORIDE manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A LEVOCABASTINE HYDROCHLORIDE supplier is an individual or a company that provides LEVOCABASTINE HYDROCHLORIDE active pharmaceutical ingredient (API) or LEVOCABASTINE HYDROCHLORIDE finished formulations upon request. The LEVOCABASTINE HYDROCHLORIDE suppliers may include LEVOCABASTINE HYDROCHLORIDE API manufacturers, exporters, distributors and traders.
click here to find a list of LEVOCABASTINE HYDROCHLORIDE suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A LEVOCABASTINE HYDROCHLORIDE DMF (Drug Master File) is a document detailing the whole manufacturing process of LEVOCABASTINE HYDROCHLORIDE active pharmaceutical ingredient (API) in detail. Different forms of LEVOCABASTINE HYDROCHLORIDE DMFs exist exist since differing nations have different regulations, such as LEVOCABASTINE HYDROCHLORIDE USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A LEVOCABASTINE HYDROCHLORIDE DMF submitted to regulatory agencies in the US is known as a USDMF. LEVOCABASTINE HYDROCHLORIDE USDMF includes data on LEVOCABASTINE HYDROCHLORIDE's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The LEVOCABASTINE HYDROCHLORIDE USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of LEVOCABASTINE HYDROCHLORIDE suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The LEVOCABASTINE HYDROCHLORIDE Drug Master File in Japan (LEVOCABASTINE HYDROCHLORIDE JDMF) empowers LEVOCABASTINE HYDROCHLORIDE API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the LEVOCABASTINE HYDROCHLORIDE JDMF during the approval evaluation for pharmaceutical products. At the time of LEVOCABASTINE HYDROCHLORIDE JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of LEVOCABASTINE HYDROCHLORIDE suppliers with JDMF on PharmaCompass.
A LEVOCABASTINE HYDROCHLORIDE CEP of the European Pharmacopoeia monograph is often referred to as a LEVOCABASTINE HYDROCHLORIDE Certificate of Suitability (COS). The purpose of a LEVOCABASTINE HYDROCHLORIDE CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of LEVOCABASTINE HYDROCHLORIDE EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of LEVOCABASTINE HYDROCHLORIDE to their clients by showing that a LEVOCABASTINE HYDROCHLORIDE CEP has been issued for it. The manufacturer submits a LEVOCABASTINE HYDROCHLORIDE CEP (COS) as part of the market authorization procedure, and it takes on the role of a LEVOCABASTINE HYDROCHLORIDE CEP holder for the record. Additionally, the data presented in the LEVOCABASTINE HYDROCHLORIDE CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the LEVOCABASTINE HYDROCHLORIDE DMF.
A LEVOCABASTINE HYDROCHLORIDE CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. LEVOCABASTINE HYDROCHLORIDE CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of LEVOCABASTINE HYDROCHLORIDE suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing LEVOCABASTINE HYDROCHLORIDE as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for LEVOCABASTINE HYDROCHLORIDE API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture LEVOCABASTINE HYDROCHLORIDE as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain LEVOCABASTINE HYDROCHLORIDE and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a LEVOCABASTINE HYDROCHLORIDE NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of LEVOCABASTINE HYDROCHLORIDE suppliers with NDC on PharmaCompass.
LEVOCABASTINE HYDROCHLORIDE Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of LEVOCABASTINE HYDROCHLORIDE GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right LEVOCABASTINE HYDROCHLORIDE GMP manufacturer or LEVOCABASTINE HYDROCHLORIDE GMP API supplier for your needs.
A LEVOCABASTINE HYDROCHLORIDE CoA (Certificate of Analysis) is a formal document that attests to LEVOCABASTINE HYDROCHLORIDE's compliance with LEVOCABASTINE HYDROCHLORIDE specifications and serves as a tool for batch-level quality control.
LEVOCABASTINE HYDROCHLORIDE CoA mostly includes findings from lab analyses of a specific batch. For each LEVOCABASTINE HYDROCHLORIDE CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
LEVOCABASTINE HYDROCHLORIDE may be tested according to a variety of international standards, such as European Pharmacopoeia (LEVOCABASTINE HYDROCHLORIDE EP), LEVOCABASTINE HYDROCHLORIDE JP (Japanese Pharmacopeia) and the US Pharmacopoeia (LEVOCABASTINE HYDROCHLORIDE USP).
LOOKING FOR A SUPPLIER?
Comment (6)
